A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

Clinical trial NCT00137969 · COMPLETED

Trial details

NCT number: NCT00137969
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Lupus Erythematosus, Systemic

Start date: 2005-05-10
Primary completion: 2008-08-25
Enrollment: 262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.